Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Latest filing published 05 Oct 2026 for Alto Neuroscience, Inc., €114k.
Filing timeline
BuySaleNicholas Conrad Smith
Insider track record
Disclosed buys
3
Disclosed sells
3
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
-19.1%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -87.6%Entry US$14.52 · Close at T+365 US$1.80
- -79.7%Entry US$16.55 · Close at T+365 US$3.36
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nicholas Conrad Smith: trading record in brief
Nicholas Conrad Smith is a declared insider of Alto Neuroscience, Inc., with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 6 February 2024 to 2 October 2026.
In open-market terms, that means 3 purchases worth €116k on one side and 3 sales worth €3.1M on the other. Sales outweigh purchases by €3.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants and 4 option exercises. Since January 2026: no purchases and 3 sales on the market.
The median purchase comes to €23k. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 5 October 2026: an option exercise of €114k, in Alto Neuroscience, Inc. The clock since the last published purchase (1 April 2024) now reads 935 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nicholas Conrad Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
55,000 shares@ US$2.32Common StockSEC:0002009130-26-000006:0
56,455 shares@ US$2.350.0094% mcap3.3% of flowCommon StockSEC:0002009130-26-000004:0
24,056 shares@ US$2.350.0040% mcap1.4% of flowCommon StockSEC:0002009130-26-000004:3
54,375 shares@ US$2.350.0091% mcap3.2% of flowCommon StockSEC:0002009130-26-000004:1
110,830 shares@ US$26.58260.21% mcap73.8% of flowCommon StockSEC:0002009130-26-000004:2
23,170 shares@ US$25.77860.043% mcap15.0% of flowCommon StockSEC:0002009130-26-000004:4
886 shares@ US$26.870.0017% mcap0.6% of flowCommon StockSEC:0002009130-26-000004:5
2,806 shares@ US$19.6950.1% of flowCommon StockSEC:0002009130-26-000002:0
1,600 shares@ US$15.8025.0% of flowCommon StockSEC:0001415889-24-009533:0
Canonical exit: 26 Jun 2024 (T+90)
19,153 shares0Common StockSEC:0001415889-24-006823:0
1,563 shares@ US$16.0024.9% of flowCommon StockSEC:0001415889-24-002940:0
Canonical exit: 6 May 2024 (T+90)
11 of 11 declarations
